X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (311) 311
porcine factor-viii (288) 288
hematology (206) 206
animals (183) 183
index medicus (121) 121
swine (108) 108
male (87) 87
biochemistry & molecular biology (84) 84
factor viii - immunology (79) 79
hemophilia (78) 78
female (74) 74
inhibitors (69) 69
factor viii (67) 67
hemophilia a - therapy (66) 66
hemophilia a - immunology (65) 65
hemophilia a - drug therapy (62) 62
antibodies (57) 57
factor viii - metabolism (55) 55
adult (51) 51
thrombin (51) 51
hemophilia-a (47) 47
peripheral vascular disease (47) 47
factor viii - therapeutic use (44) 44
factor-viii inhibitors (42) 42
middle aged (42) 42
vonwillebrand-factor (41) 41
porcine factor viii (40) 40
activated protein-c (39) 39
aged (38) 38
kinetics (38) 38
recombinant factor viia (38) 38
recombinant proteins - therapeutic use (38) 38
factor viii - antagonists & inhibitors (37) 37
factor viii - chemistry (36) 36
factor viii - genetics (35) 35
factor viiia - metabolism (35) 35
von-willebrand-factor (35) 35
a1/a3-c1-c2 dimer (34) 34
factor-ixa (34) 34
haemophilia (34) 34
hemophilia a - blood (34) 34
blood coagulation factor viii (33) 33
surgery (33) 33
therapy (33) 33
management (32) 32
transplantation (32) 32
coagulation-factor-viii (31) 31
immune tolerance (31) 31
medicine, research & experimental (31) 31
mice (31) 31
concentrate (30) 30
inactivation (30) 30
activated factor-vii (29) 29
hemophilia a - complications (29) 29
porcine (29) 29
recombinant factor-viia (29) 29
amino acid sequence (28) 28
factor-ix inhibitors (28) 28
hemophilia a (28) 28
inhibitor (28) 28
safety (28) 28
molecular sequence data (27) 27
acquired hemophilia (26) 26
binding sites (26) 26
bleeding (26) 26
factor ixa - metabolism (26) 26
research (26) 26
factor-ix (25) 25
immunosuppressive therapy (25) 25
light-chain (25) 25
blood-coagulation (24) 24
factor viia - therapeutic use (24) 24
protein binding (24) 24
recombinant factor-viii (24) 24
activation (23) 23
autoantibodies - immunology (23) 23
binding-site (23) 23
factor viii - administration & dosage (23) 23
factor viiia - chemistry (23) 23
factor-x (23) 23
factor-xa (23) 23
gene therapy (23) 23
autoantibodies (22) 22
coagulation factors (22) 22
hemophilia a - etiology (22) 22
procoagulant activity (22) 22
recombinant proteins - metabolism (22) 22
biotechnology & applied microbiology (21) 21
child (21) 21
aged, 80 and over (20) 20
continuous-infusion (20) 20
diagnosis (20) 20
hemophilia a - diagnosis (20) 20
hemorrhage - etiology (20) 20
pregnancy (20) 20
subunit structure (20) 20
treatment outcome (20) 20
von willebrand factor (20) 20
xenotransplantation (20) 20
autoantibodies - blood (19) 19
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (455) 455
French (6) 6
German (6) 6
Japanese (3) 3
Russian (2) 2
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 07/2008, Volume 112, Issue 2, pp. 250 - 255
Journal Article
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 01/2020, Volume 18, Issue 1, pp. 36 - 43
Background Recombinant porcine factor VIII (rpFVIII, OBI‐1, susoctocog alfa) is used for the treatment of acute bleeds in patients with acquired hemophilia A... 
porcine factor VIII | bleeding | susoctocog alfa | acquired hemophilia | inhibitor | ANTIBODIES | EFFICACY | ADULTS | CONGENITAL HEMOPHILIA | SEQUENCE FACTOR-VIII | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | ELISA | Coagulation factors | Enzyme-linked immunosorbent assay | Hemophilia
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 10/2017, Volume 15, Issue 10, pp. 1994 - 2004
Essentials The immune response is a significant concern in gene therapy. Platelet‐targeted gene therapy can restore hemostasis and induce immune tolerance. CD4... 
hemophilia A | gene therapy | platelet | factor VIII | immune tolerance induction | RESTORES HEMOSTASIS | FVIII IMMUNITY | PHENOTYPIC CORRECTION | B-CELLS | MURINE MODEL | NAKED DNA TRANSFER | REGULATORY CELLS | HEMATOPOIETIC STEM-CELLS | PERIPHERAL VASCULAR DISEASE | INHIBITOR DEVELOPMENT | PORCINE FACTOR-VIII | HEMATOLOGY | Factor VIII - immunology | Blood Platelets - immunology | Humans | Male | T-Lymphocytes, Regulatory - immunology | Bone Marrow Transplantation | Female | Immunosuppressive Agents - pharmacology | Disease Models, Animal | Immune Tolerance - drug effects | B-Lymphocytes - enzymology | Genetic Predisposition to Disease | Transduction, Genetic | Lymphocyte Activation | Hemophilia A - immunology | Mice, Inbred C57BL | Cells, Cultured | Factor VIII - genetics | Hemophilia A - therapy | Hemophilia A - blood | Mice, Knockout | Phenotype | T-Lymphocytes, Regulatory - drug effects | Animals | Blood Platelets - metabolism | Antibodies - blood | Immunologic Memory | Hemophilia A - genetics | Factor VIII - biosynthesis | Genetic Therapy - methods | Immune response | Blood coagulation factor VIII | Analysis | Genes | Hemophilia | Genetic research | B cells | T cells | Gene therapy | Cell proliferation | Memory cells | Immunological memory | Medical immunity | Radiation | Antibodies | Lymphocytes T | Transplantation | Immunological tolerance | Bleeding | CD4 antigen | Coagulation factors | Lymphocytes B | Hemostasis | Lymphocytes | Busulfan | Platelets | Enzyme-linked immunosorbent assay | Platelet | Immune tolerance induction | Gene Therapy | Hemophilia A | Factor VIII
Journal Article
Haemophilia, ISSN 1351-8216, 01/2017, Volume 23, Issue 1, pp. 25 - 32
Introduction A recombinant porcine factor VIII B‐domain‐deleted product (rpFVIII; OBIZUR, Baxalta Incorporated, Deerfield, IL 60015, USA) was recently approved... 
porcine factor VIII | acquired haemophilia A | MANAGEMENT | EACH2 | HEMATOLOGY | REGISTRY | Recombinant Proteins - therapeutic use | Humans | Middle Aged | Male | Treatment Outcome | Hemophilia A - therapy | Young Adult | Animals | Swine | Aged, 80 and over | Female | Aged | Retrospective Studies | Hemophilia A - drug therapy | Usage | Blood coagulation factor VIII | Coagulation factors | Early experience | Bleeding | Hemophilia
Journal Article
Haemophilia, ISSN 1351-8216, 03/2016, Volume 22, Issue 2, pp. 308 - 317
Journal Article
Haemophilia, ISSN 1351-8216, 09/2012, Volume 18, Issue 5, pp. 798 - 804
Journal Article